Navigation Links
Today on Capitol Hill: The Malaria Forum
Date:4/21/2009

- Interdisciplinary team of experts joins forces to discuss the latest tools to combat this preventable but deadly disease -

BRIDGEWATER, N.J., April 21 /PRNewswire/ -- Today on Capitol Hill Congressmen Don Payne and John Boozman, co-chairs of the Congressional Malaria Caucus, join global pharmaceutical company sanofi-aventis and the non-profit Drugs for Neglected Disease initiative (DNDi) to host the Malaria Forum. The Malaria Forum offers an important opportunity to gain insights on health initiatives and partnerships that are focused on combating this dreaded disease worldwide.

Every year, as many as one million people die from malaria and another 300-500 million suffer from it. Malaria remains the leading cause of death for children under the age of five in Africa, and kills one child every 30 seconds worldwide.

The sanofi-aventis group has been present in Africa for decades and extensively in countries affected by malaria. In 2001, the Impact Malaria initiative, the first program from the sanofi-aventis Access to Medicines team was created mobilizing the company's expertise and resources to fight diseases including malaria.

DNDi, an independent, non-profit pharmaceutical research and development (R&D) organization, has been involved in developing and making available needs-adapted treatments for a group of deadly neglected diseases traditionally ignored by market-driven mechanisms for drug development. Since its founding in 2003, DNDi has already developed and made available two antimalarial medicines while reaching out in partnership to those in the remotest areas in Africa as well as the largest pharmaceutical companies in the world.

Dr. Francois Bompart, who is part of the sanofi-aventis group's Access to Medicine team, will discuss the importance of educating communities, healthcare professionals and families about malaria and adapting medicines to meet patient needs. "Our mission is to bring together all of sanofi-aventis' expertise in order to provide patients in developing countries with access to medicines and vaccines for specific diseases, such as malaria. However, based on the knowledge that medicines alone cannot solve all problems we are also involved in education, information and prevention initiatives in these countries. We are deeply committed to our continued efforts in promoting better health for patients worldwide and to satisfy unmet healthcare needs."

Hellen Gelband, a malaria expert and member of the Board of Directors of DNDi North America, will discuss the impact and needs of patients with neglected diseases like malaria, with a focus on how the medicine, ASAQ (artesunate-amodiaquine)(1) was developed in partnership with sanofi-aventis. In addition, Ms. Gelband will discuss why various types of partners, from the public and private sectors, are critical in addressing the global health imbalance and how DNDi is utilizing a wide array of partnerships in its patient-driven drug development model, which is already delivering concrete benefits to patients in the form of two new malaria drugs in use in the field.

The Malaria Forum will take place on Tuesday, April 21 from 3:00 PM - 4:30 PM at 2200 Rayburn House Office Building. It is not open to the public.

(1) ASAQ is not approved in the U.S.

About sanofi-aventis

Sanofi-aventis is a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients and their families. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi-aventis U.S. is a U.S. affiliate of sanofi-aventis. For more information, visit www.sanofi-aventis.us or www.sanofi-aventis.com

US.COR.09.04.024

    Contact:
    Elizabeth Baxter - sanofi-aventis, +1-908-981-5360
    elizabeth.baxter@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Good News for Tough Times: Small, Private University Responds to Todays Economic Challenges
2. City of Warrensville Heights Residents Have Access to Easy-to-Use Prescription Drug Discount Card Launched Today
3. TopBestPennyStocks.com Issues Technical Trade Alerts on Hot Stocks in the Market Today: CAST, VM, NFLX, PFE, AA, & COF
4. National Physicians Study: Nearly One Third Would Choose Different Career Today
5. Americas Egg Farmers to Participate in Annual White House Easter Egg Roll Today
6. Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinsons Disease
7. MedPage Today Pledges to Maintain and Expand News Coverage in 2009
8. Mayer Labs Acquires Today(R) Sponge Distribution Rights
9. National Public Health Week Begins Today With Launch of Viral Video Campaign
10. Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines
11. Smokers Have Greater Incentive to Quit, as Big Tobacco Tax Hike Goes Into Effect Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: